Is Chronic AhR Activation by Rapidly Metabolized Ligands Safe for the Treatment of Immune-Mediated Diseases?
Current Opinion in Toxicology - Netherlands
doi 10.1016/j.cotox.2017.01.007
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2017
Authors
Publisher
Elsevier BV